Preclinical evaluation of a novel allosteric IL-1R inhibitor (rytvela) for the prevention of perinatal inflammation-induced fetal injury

  • Keelan, Jeffrey A (Primary Chief Investigator (PCI))
  • Olson, David M (Chief Investigator (CI))
  • Robertson, Sarah A. (Chief Investigator (CI))
  • Kemp, Matthew W (Chief Investigator (CI))
  • Dickinson, Hayley (Chief Investigator (CI))
  • Ellery, Stacey (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date1/01/1831/12/21


  • National Health and Medical Research Council (NHMRC) (Australia): A$1,377,827.40